Sustained delivery of commensal bacteria from pod-intravaginal rings

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2262-2267

  Gunawardana, Manjula ^a   Mullen, Madeline ^a   Yoo, Jennifer ^a   Webster, Paul ^a   Moss, John A ^a   Baum, Marc M ^a  

^a OAK CREST INSTITUTE OF SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMER; PROBIOTIC AGENT; SILICONE;

ARTICLE; BACTERIAL CELL; BACTERIUM; BIOFILM; COMMENSAL; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; IN VITRO STUDY; LACTOBACILLUS GASSERI; MICROORGANISM; NONHUMAN; POD; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TECHNOLOGY; UROGENITAL SYSTEM; VAGINA FLORA;

ADMINISTRATION, INTRAVAGINAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LACTOBACILLUS; PROBIOTICS; VAGINA;

EID: 84896959018     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02542-13     Document Type: Article

References (51)

1. Creese A, Floyd K, Alban A, Guinness L. 2002. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 359:1635-1642. http://dx.doi.org/10.1016/S0140-6736(02)08595-1. (Pubitemid 34518522)
2. Bolton M, van der Straten A, Cohen CR. 2008. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex. Transm. Dis. 35:214-225. http://dx.doi.org/10.1097/OLQ.0b013e31815b017a. (Pubitemid 351619515)
3. Reid G, Jass J, Sebulsky MT, McCormick JK. 2003. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 16:658-672. http://dx.doi.org/10.1128/CMR.16.4.658-672.2003. (Pubitemid 37296554)
4. Reid G. 2012. Probiotic and prebiotic applications for vaginal health. J. AOAC Int. 95:31-34. http://dx.doi.org/10.5740/jaoacint.SGE-Reid.
5. Falagas ME, Betsi GI, Athanasiou S. 2007. Probiotics for the treatment of women with bacterial vaginosis. Clin. Microbiol. Infect. 13:657-664. http://dx.doi.org/10.1111/j.1469-0691.2007.01688.x. (Pubitemid 46909341)
6. Hummelen R, Changalucha J, Butamanya NL, Cook A, Habbema JD, Reid G. 2010. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int. J. Gynaecol. Obstet. 111:245-248. http://dx.doi.org/10.1016/j.ijgo.2010.07.008.
7. Marcone V, Rocca G, Lichtner M, Calzolari E. 2010. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int. J. Gynaecol. Obstet. 110:223-226. http://dx.doi.org/10.1016/j.ijgo.2010.04.025.
8. Ya W, Reifer C, Miller LE. 2010. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am. J. Obstet. Gynecol. 203:120.e1-e6. http://dx.doi.org/10.1016/j.ajog.2010.05.023.
9. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. 2006. Apilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int. J. Antimicrob. Agents 28(Suppl 1):S30 -S34. http://dx.doi.org/10.1016/j. ijantimicag.2006.05.008.
10. Darouiche RO, Hull RA. 2012. Bacterial interference for prevention of urinary tract infection. Clin. Infect. Dis. 55:1400-1407. http://dx.doi.org/10. 1093/cid/cis639.
11. Reid JNS, Bisanz JE, Monachese M, Burton JP, Reid G. 2013. The rationale for probiotics improving reproductive health and pregnancy outcome. Am. J. Reprod. Immunol. 69:558-566. http://dx.doi.org/10.1111/aji.12086.
12. Stevens R, LaVoy A, Nordone S, Burkhard M, Dean GA. 2005. Preexisting immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine. Vaccine 23:1479-1490. http://dx.doi.org/10.1016/ j.vaccine.2004.09.033. (Pubitemid 40164708)
13. Jiang SS, Rasmussen RA, Nolan KM, Frankel FR, Lieberman J, McClure HM, Williams KM, Babu US, Raybourne RB, Strobert E, Ruprecht RM. 2007. Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys. Vaccine 25:7470-7479. http://dx.doi.org/10.1016/j.vaccine.2007.08.013. (Pubitemid 47484002)
14. Chang TL, Chang CH, Simpson DA, Xu Q, Martin PK, Lagenaur LA, Schoolnik GK, Ho DD, Hillier SL, Holodniy M, Lewicki JA, Lee PP. 2003. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc. Natl. Acad. Sci. U. S. A. 100:11672-11677. http://dx.doi.org/10.1073/pnas.1934747100. (Pubitemid 37205993)
15. Lagenaur LA, Sanders-Beer BE, Brichacek B, Pal R, Liu X, Liu Y, Yu R, Venzon D, Lee PP, Hamer DH. 2011. Prevention of vaginal SHIV transmission in macaques by a live recombinant lactobacillus. Mucosal Immunol. 4:648-657. http://dx.doi.org/10.1038/mi.2011.30.
16. Orr MT, Orgun NN, Wilson CB, Way SS. 2007. Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection. J. Immunol. 178:4731-4735. (Pubitemid 46595253)
17. Medaglini D, Rush CM, Sestini P, Pozzi G. 1997. Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice. Vaccine 15:1330-1337. http://dx.doi.org/10.1016/S0264-410X(97)00026-1. (Pubitemid 27397808)
18. Echchannaoui H, Bianchi M, Baud D, Bobst M, Stehle JC, Nardelli-Haefliger D. 2008. Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect. Immun. 76:1940-1951. http://dx.doi.org/10.1128/IAI.01484-07. (Pubitemid 351656127)
19. Di Fabio S, Medaglini D, Rush CM, Corrias F, Panzini GL, Pace M, Verani P, Pozzi G, Titti F. 1998. Vaginal immunization of cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens. Vaccine 16:485-492. http://dx.doi.org/10.1016/S0264-410X(97)80002-3. (Pubitemid 28044166)
20. Saxena M, Van TT, Baird FJ, Coloe PJ, Smooker PM. 2013. Pre-existing immunity against vaccine vectors-friend or foe? Microbiology 159:1-11. http://dx.doi.org/10.1099/mic.0.049601-0.
21. Maggi L, Mastromarino P, Macchia S, Brigidi P, Pirovano F, Matteuzzi D, Conte U. 2000. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur. J. Pharm. Biopharm. 50:389 -395. http://dx.doi.org/10.1016/S0939-6411(00)00121-1.
22. Eriksson K, Carlsson B, Forsum U, Larsson PG. 2005. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm. Venereol. 85:42-46. http://dx.doi.org/10.1080/00015550410022249. (Pubitemid 40254678)
23. Malcolm RK, Edwards KL, Kiser P, Romano J, Smith TJ. 2010. Advances in microbicide vaginal rings. Antiviral Res. 88:S30-S39. http://dx.doi.org/10.1016/ j.antiviral.2010.09.003.
24. Moss JA, Malone AM, Smith TJ, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Vincent KL, Motamedi M, Friend DR, Clark MR, Baum MM. 2012. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob. Agents Chemother. 56:875-882. http://dx.doi.org/10.1128/AAC.05662- 11.
25. Keller MJ, Malone AM, Carpenter CA, Lo Y, Huang M, Corey L, Willis R, Nguyen C, Kennedy S, Gunawardana M, Guerrero D, Moss JA, Baum MM, Smith TJ, Herold BC. 2012. Safety and pharmacokinetics of acyclovir in women following release from a silicone elastomer vaginal ring. J. Antimicrob. Chemother. 67:2005-2012. http://dx.doi.org/10.1093/jac/dks151.
26. Kiser PF, Johnson TJ, Clark JT. 2012. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev. 14:62-77.
27. Baum MM, Butkyavichene I, Gilman J, Kennedy S, Kopin E, Malone AM, Nguyen C, Smith TJ, Friend DR, Clark MR, Moss JA. 2012. An intravaginal ring for the simultaneous delivery of multiple drugs. J. Pharm. Sci. 101:2833-2843. http://dx.doi.org/10.1002/jps.23208.
28. Lauer E, Kandler O. 1980. Lactobacillus gasseri sp. nov., a new species of the subgenus Thermobacterium. Zentralbl. Bakteriol. Orig. A 1:75-78. (Article in German.) (Pubitemid 11068656)
29. Azcarate-Peril MA, Altermann E, Goh YJ, Tallon R, Sanozky-Dawes RB, Pfeiler EA, O'Flaherty S, Buck BL, Dobson A, Duong T, Miller MJ, Barrangou R, Klaenhammer TR. 2008. Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism. Appl. Environ. Microbiol. 74: 4610-4625. http://dx.doi.org/10.1128/AEM.00054-08.
30. Myers JA, Curtis BS, Curtis WR. 2013. Improving accuracy of cell and chromophore concentration measurements using optical density. BMC Biophysics 6:4. http://dx.doi.org/10.1186/2046-1682-6-4.
31. Webster P, Wu S, Webster S, Rich KA, McDonald K. 2004. Ultrastructural preservation of biofilms formed by non-typeable Haemophilus influenzae. Biofilms 1:165-182. http://dx.doi.org/10.1017/S1479050504001425.
32. Baum MM, Kainovič A, O'Keeffe T, Pandita R, McDonald K, Wu S, Webster P. 2009. Characterization of structures in biofilms formed by a Pseudomonas fluorescens isolated from soil. BMC Microbiol. 9:103. http://dx.doi.org/10.1186/1471-2180-9-103.
33. Moss JA, Baum MM, Malone AM, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Willis R, Vincent KL, Motamedi M, Smith TJ. 2012. Tenofovir and tenofovir disoproxil pharmacokinetics from intravaginal rings. AIDS 26:707-710. http://dx.doi.org/10.1097/QAD.0b013e3283509abb.
34. Moss JA, Malone AM, Smith TJ, Butkyavichene I, Cortez C, Gilman J, Kennedy S, Kopin E, Nguyen C, Sinha P, Hendry RM, Guenthner P, Holder A, Martin A, McNicholl J, Mitchell J, Pau CP, Srinivasan P, Smith JM, Baum MM. 2012. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques. Antimicrob. Agents Chemother. 56:5952-5960. http://dx.doi.org/10.1128/AAC.01198-12.
35. de Leede LG, Govers CP, de Nijs H. 1986. A multi-compartment vaginal ring system for independently adjustable release of contraceptive steroids. Contraception 34: 589-602. http://dx.doi.org/10.1016/S0010-7824(86)80015-4. (Pubitemid 17009973)
36. Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. 2010. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur. J. Pharm. Sci. 39:203-212. http://dx.doi.org/10.1016/j.ejps.2009.11.007.
37. Henzl MR, Mishell DR, Jr, Velazquez JC, Leitch WE. 1973. Basic studies for prolonged progestogen administration by vaginal devices. Am. J. Obstet. Gynecol. 117:101-106.
38. Johnson TJ, Clark MR, Albright TH, Nebeker JS, Tuitupou AL, Clark JT, Fabian J, McCabe RT, Chandra N, Doncel GF, Friend DR, Kiser PF. 2012. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrob. Agents Chemother. 56:6272-6283. http://dx.doi.org/10.1128/AAC.01431-12.
39. Moss JA, Malone AM, Smith TJ, Kennedy S, Nguyen C, Vincent KL, Motamedi M, Baum MM. 2013. Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in the ovine model. Antimicrob. Agents Chemother. 57:3994-3997. http://dx.doi.org/10.1128/AAC.00547-13.
40. Gunawardana M, Moss JA, Smith TJ, Kennedy S, Kopin E, Nguyen C, Malone AM, Rabe L, Schaudinn C, Webster P, Srinivasan P, Sweeney ED, Smith JM, Baum MM. 2011. Microbial biofilms on the surface of intravaginal rings worn in non-human primates. J. Med. Microbiol. 60:828-837. http://dx.doi.org/10.1099/jmm.0. 028225-0.
41. Ursell LK, Gunawardana M, Chang S, Mullen M, Moss JA, Herold BC, Keller MJ, McDonald D, González A, Knight R, Baum MM. 2014. Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings. Antiviral Res. 102:87-94. http://dx.doi.org/10. 1016/j.antiviral.2013.12.004.
42. Reid G, Beuerman D, Heinemann C, Bruce AW. 2001. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32:37-41. http://dx.doi.org/10.1111/j.1574-695X.2001.tb00531.x. (Pubitemid 34025073)
43. Feiks A, Grünberger W. 1991. Therapy of atrophic colpitis-is a reduction of estrogen dosage in local administration possible? Gynakol. Rundsch. 31(Suppl 2):268-271. (In German.)
44. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, Kaiser RR. 1996. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung 46:68-73.
45. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. 2005. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 112:234-240. http://dx.doi.org/10.1111/j.1471-0528.2004.00329.x. (Pubitemid 40188254)
46. Friedlander A, Druker MM, Schachter A. 1986. Lactobacillus acidophillus and vitamin B complex in the treatment of vaginal infection. Panminerva Med. 28:51-53.
47. Gorby YA, Yanina S, McLean JS, Rosso KM, Moyles D, Dohnalkova A, Beveridge TJ, Chang IS, Kim BH, Kim KS, Culley DE, Reed SB, Romine MF, Saffarini DA, Hill EA, Shi L, Elias DA, Kennedy DW, Pinchuk G, Watanabe K, Ishii S, Logan B, Nealson KH, Fredrickson JK. 2006. Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganisms. Proc. Natl. Acad. Sci. U. S. A. 103:11358-11363. http://dx.doi.org/10.1073/pnas.0604517103. (Pubitemid 44156522)
48. Schaudinn C, Stoodley P, Kainovič A, O'Keeffe T, Costerton JW, Robinson DH, Baum MM, Ehrlich G, Webster PS. 2007. Bacterial biofilms, other structures seen as mainstream concepts. Microbe 2:231-237. (Pubitemid 47611959)
49. Fredricsson B, Englund K, Weintraub L, Olund A, Nord CE. 1989. Bacterial vaginosis is not a simple ecological disorder. Gynecol. Obstet. Invest. 28:156-160. http://dx.doi.org/10.1159/000293556. (Pubitemid 19254299)
50. Hallén A, Jarstrand C, Påhlson C. 1992. Treatment of bacterial vaginosis with lactobacilli. Sex. Transm. Dis. 19:146-148. http://dx.doi.org/10.1097/00007435-199205000-00007.
51. Neri A, Sabah G, Samra Z. 1993. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obst. Gynecol. Scand. 72:17-19. http://dx.doi.org/10.3109/ 00016349309013342. (Pubitemid 23074897)